Nabiey Romin 4

What Happened

• Nabiey Romin, Chief Accounting Officer of GoodRx (GDRX), had 12,663 restricted stock units (RSUs) convert into 12,663 shares on Feb 8, 2026. To satisfy tax withholding, 5,215 of those shares were surrendered at a withholding value of $2.44 per share, totaling $12,725. Net shares delivered to Romin from this vesting/event were 7,448 shares (12,663 converted − 5,215 withheld).
• This was not an open‑market sale — it was a routine conversion/settlement of RSUs with shares withheld to cover tax obligations.

Key Details

• Transaction date: February 8, 2026; Form 4 filed Feb 9, 2026 (timely filing).
• Actions reported: Code M — conversion/exercise of a derivative (12,663 RSUs converted to shares); Code F — payment of tax liability via withholding of 5,215 shares at $2.44/share = $12,725.
• Net shares received by insider: 7,448 shares.
• Footnotes: F1 — each RSU represents a contingent right to one share of Class A common stock. F2 — these RSUs vest 6.25% on Aug 8, 2023 and the remaining 93.75% in roughly equal quarterly installments over 15 quarters.
• Shares owned after the transaction (total beneficial ownership) are not provided in the excerpt; the reported change is the net 7,448 shares added to Romin’s holdings from this conversion.

Context

• This is a common settlement of restricted stock units; the withheld shares were used to pay tax liabilities (routine administrative action), not a signal of a discretionary market sale.
• Transaction codes: M = derivative exercise/conversion (RSU settlement), F = tax withholding/payment.